Phase II study of FOLFOX, bevacizumab and erlotinib as first-line therapy for patients with metastastic colorectal cancer
| Autor: | Meyerhardt, J.A. *, Stuart, K. †, Fuchs, C.S., Zhu, A.X., Earle, C.C., Bhargava, P., Blaszkowsky, L., Enzinger, P., Mayer, R.J., Battu, S., Lawrence, C., Ryan, D.P. |
|---|---|
| Zdroj: | In Annals of Oncology July 2007 18(7):1185-1189 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|